Spearhead Bio, Inc.
Other Technology · Saint Louis, Missouri
Spearhead Bio, Inc. is a other technology company based in Saint Louis, Missouri, incorporated in 2024. It has raised at least $2.2 million across 1 known rounds, of which $1.0 million was reported to the SEC on 1 Form D filing, most recently in 2025.
Portfolio Companies Spearhead Bio Spearhead Bio leads the next generation of powerful native genome engineering tools to accelerate the development and launch of new transgenic & non-transgenic crops. Harnessing Nature to Transform Agriculture With Spearhead Bio’s flagship technology, we can significantly enhance the efficiency of crop genome engineering using the plant’s natural DNA while ensuring…
| Date | Round | Amount | Raised to date | Lead investor | Source |
|---|---|---|---|---|---|
| 2026-06-23 | — | $1.2M | $2.2M | SEC Form D | |
| 2025-02-21 | — | $1.0M | $1.0M | SEC Form D |
SEC rows are Form D filings, where the amount is what was actually sold and amendments update a round rather than adding one. Press rows are split between company-issued releases or wires and editorial or third-party coverage. The total is therefore a floor: a round nobody reported is a round we cannot see. A buyout or control change appears in the timeline but is never added to the total: that money goes to shareholders, not into the company.
Form D is the notice a company files with the SEC when it sells securities without registering them. It reports the amount sold, not a valuation. Figures here are what the filing says. Where a filing is silent, the field is left blank rather than estimated. “Total raised” adds press-reported rounds that never appear in a filing, so it is a floor rather than an audited sum: press amounts are the figures the company announced, and a round nobody reported is a round we cannot see.